MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term investments$131,441K Cash and cashequivalents$96,280K Accounts receivable$17,243K Prepaid expenses andother current assets$8,582K Total current assets$253,546K Other assets$14,066K Right-of-use asset$4,254K Total assets$271,866K Total liabilities andstockholders' equity$271,866K Total stockholders'equity$233,253K Total liabilities$38,613K Accumulated deficit-$773,198K Additional paid-in capital$911,014K Total currentliabilities$23,517K Deferred revenue, net ofcurrent portion$12,041K Operating leaseliabilities, net of current...$3,055K Preferred stock-SeriesXRedeemable Convertible...$95,324K Common stock, 0.001 parvalue per share,...$57K Accumulated othercomprehensive gain$56K Accrued expenses$16,481K Deferred revenue,current$4,495K Operating leaseliabilities, current$1,404K Accounts payable$1,137K
Balance Sheet
source: myfinsight.com

Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics, Inc. (ATXS)